↓ Skip to main content

Novel Oral Anticoagulants Versus Warfarin Therapy at Various Levels of Anticoagulation Control in Atrial Fibrillation—A Cost-Effectiveness Analysis

Overview of attention for article published in Journal of General Internal Medicine, October 2013
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

news
6 news outlets
blogs
1 blog

Citations

dimensions_citation
46 Dimensions

Readers on

mendeley
86 Mendeley
Title
Novel Oral Anticoagulants Versus Warfarin Therapy at Various Levels of Anticoagulation Control in Atrial Fibrillation—A Cost-Effectiveness Analysis
Published in
Journal of General Internal Medicine, October 2013
DOI 10.1007/s11606-013-2639-2
Pubmed ID
Authors

Joyce H. S. You

Abstract

The decision as to whether to use more expensive novel oral anticoagulants (NOACs) or invest resources for quality improvement of warfarin therapy requires input from both clinical and economic analyses.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 86 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 3 3%
Iran, Islamic Republic of 1 1%
Portugal 1 1%
Slovenia 1 1%
Unknown 80 93%

Demographic breakdown

Readers by professional status Count As %
Student > Master 13 15%
Student > Bachelor 13 15%
Researcher 8 9%
Student > Ph. D. Student 8 9%
Student > Postgraduate 5 6%
Other 19 22%
Unknown 20 23%
Readers by discipline Count As %
Medicine and Dentistry 35 41%
Pharmacology, Toxicology and Pharmaceutical Science 10 12%
Economics, Econometrics and Finance 5 6%
Mathematics 4 5%
Nursing and Health Professions 2 2%
Other 7 8%
Unknown 23 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 49. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 October 2013.
All research outputs
#790,555
of 23,911,072 outputs
Outputs from Journal of General Internal Medicine
#667
of 7,806 outputs
Outputs of similar age
#7,306
of 215,896 outputs
Outputs of similar age from Journal of General Internal Medicine
#12
of 79 outputs
Altmetric has tracked 23,911,072 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 7,806 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.8. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 215,896 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 79 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.